Clostridium difficile

(redirected from Cdiff)
Also found in: Medical.

Clostridium difficile

(dɪˈfɪsɪli; ˌdɪfɪˈsiːl)
n
(Pathology) a faecal organism endemic in hospitals and responsible for the majority of hospital-acquired cases of diarrhoea in elderly patients. Sometimes shortened to: C.difficile or C.diff
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
References in periodicals archive ?
In our laboratory, the successful verification and implementation of the BD MAX EBP, Cdiff, and StaphSR assays allowed consolidation of three different tests using three different methodologies to one platform.
Supplier: Tru-D Size: 65-inches tall Type of light: UV-C Run time: Typically 45-minute cycle, 1 cycle per room Self-reported kill rate: Third party validations 3-4 [Log.sub.10] pathogen reduction in direct and indirect shadowed areas (Cdiff, MRSA, VRE, Acinetobacter)
Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C.
Dr Wells said: "Faecal transplantation doesn't sound appealing but it's very effective with serious CDiff infection."
The 75-year-old, who lives in Eaglescliffe with wife Thelma, suffered from constant pain and diarrhoea as a result of the bowel infection Clostridium Difficile (CDiff ).
The latest figures show hospital acquired infections like MRSA and CDIFF showed a rate of zero per cent The 27-bed hospital, which celebrated its 25th anniversary last year and is part of the Spire Healthcare group, carries out 2,000 operations a year and employs 115 people.
The company also profited from a stronger flu season in 2013 and the FDA approvals of its BD Max Cdiff Assay in the United States, the BD ProbeTec Trichomonas Vaginalis Qx Amplified DNA Assay, and the nasopharyngeal wash, aspirate and swab in transport media specimens on the BD Veritor System for the rapid detection of respiratory syncytial virus.
Moeslein, RN, MSA, CIC, Infection Prevention Nurse Manager from Riverside Regional Medical Center, who will discuss 'Tales from the Trenches: How Our Facility Implemented and Evaluated UV Technology to Reduce MDROs and Cdiff.” George J.
M2 PHARMA-March 19, 2014-Roche unveils CE-IVD launch of cobas Cdiff Test
Food and Drug Administration clearance to market the BD MAX Cdiff Assay in the United States.